8/10/2016
`
`Teva Pharm finalizing asset sales to clear Allergan deal source | Reuters
`
`MORNING BRIEFING: A call to arms? Or a polite request to vote? VIEW MORE
`
`EDITION: UNITED STATES
`
`SIGN IN
`
`Business
`
`Markets World
`
`
`
`
`
`
`Politics
`
`Tech
`
`
`
`
`
`Commentary
`
`
`
`Breakingviews
`
`Money
`
`
`
`
`
`Rio 2016
`
`
`
`
`
`Markets | Thu May 5, 2016 4:12pm EDT
`
`Teva Pharm finalizing asset sales to clear Allergan deal -
`source
`
`Related: STOCKS, REGULATORY NEWS, M&A, MARKETS
`
`BY CARL O'DONNELL
`
`May 5 Teva Pharmaceutical Industries Ltd is finalizing as much as $2 billion in asset sale
`agreements to win U.S. antitrust clearance for its $40.5 billion acquisition of Allergan Plc's
`generic drug portfolio, according to a source familiar with the matter.
`
`BREAKINGVIEWS
`
`The divestments would boost efforts by Teva, the Israeli pharmaceutical company, to close
`the deal with Allergan, which is domiciled in Ireland. Teva said in March that a regulatory
`review of the deal by the U.S. Federal Trade Commission was taking longer than
`anticipated, and that it expected the transaction to be completed by June.
`
`Teva has found buyers for nearly all of the assets it expects to divest, which could be worth
`as much as $2 billion in total, the source said on Thursday. They include around 50 drugs
`already on the market and 25 in development that treat illnesses ranging from cancer to
`respiratory disease and central nervous system disorders, the source said.
`
`Teva is still on track to close the deal next month, the source added, asking not to be
`identified because the latest developments are not public. Teva declined to comment,
`Allergan did not immediately respond to requests for comment. (Reporting by Carl
`O'Donnell; Editing by David Gregorio)
`
`More from Reuters
`
`Sponsored Financial Content
`
` (?)
`
`Trumponomics favors pinstripes over
`blue collars
`
`Jim Rickards: "DO NOT buy any gold until
`you see this" Agora Financial
`
`A massive stock market rally is at our
`doorsteps, according to ... The Sovereign Society
`
`A jawdropping 21 month 0% interest rate
`credit card has been announce Next Advisor
`
`How 1 Man Turned $50,000 into $5.3 Million
` Investing Daily
`
`Donald Trump's Advice For Paying Off
`Mortgage (It's Genius!) Bills.com
`
`Swimming: Thirteen
`yearold rips suit but
`wins her heat | 7 Aug
`
`Obama warns Trump
`not to spread details
`of security briefings
`| 4 Aug
`
`Commentary: Here’s
`how a U.S.China war
`could play out | 9 Aug
`
`Hollande says will
`stay true to values
`after Trump swipe at
`France | 28 Jul
`
`Home flight
`simulator in MH370
`captain's home
`plotted Indian Ocean
`course: JACC | 28 Jul
`
`Beach Volleyball:
`Crowd taunts U.S.
`players with 'Zika'
`jeers | 7 Aug
`
`RIO OLYMPICS IN PICTURES
`
`http://www.reuters.com/article/allerganmatevapharmindassetsidUSL2N1820VD
`
`1/4
`
`Dr. Reddy's Labs. v. Indivior UK Ltd, IPR2016-01113
`INDIVIOR EX. 2008 - 1/4
`
`
`
`Teva Pharm finalizing asset sales to clear Allergan deal source | Reuters
`
`MORNING BRIEFING: A call to arms? Or a polite request to vote? VIEW MORE
`
`EDITION: UNITED STATES
`
`SIGN IN
`
`Business
`
`Markets World
`
`
`
`
`
`
`Politics
`
`Tech
`
`
`
`
`
`Commentary
`
`
`
`Breakingviews
`
`Money
`
`
`
`
`
`Rio 2016
`
`
`
`
`
`Markets | Thu May 5, 2016 4:12pm EDT
`
`Teva Pharm finalizing asset sales to clear Allergan deal -
`source
`
`Related: STOCKS, REGULATORY NEWS, M&A, MARKETS
`
`BY CARL O'DONNELL
`
`May 5 Teva Pharmaceutical Industries Ltd is finalizing as much as $2 billion in asset sale
`agreements to win U.S. antitrust clearance for its $40.5 billion acquisition of Allergan Plc's
`generic drug portfolio, according to a source familiar with the matter.
`
`BREAKINGVIEWS
`
`The divestments would boost efforts by Teva, the Israeli pharmaceutical company, to close
`the deal with Allergan, which is domiciled in Ireland. Teva said in March that a regulatory
`review of the deal by the U.S. Federal Trade Commission was taking longer than
`anticipated, and that it expected the transaction to be completed by June.
`
`Teva has found buyers for nearly all of the assets it expects to divest, which could be worth
`as much as $2 billion in total, the source said on Thursday. They include around 50 drugs
`already on the market and 25 in development that treat illnesses ranging from cancer to
`respiratory disease and central nervous system disorders, the source said.
`
`Teva is still on track to close the deal next month, the source added, asking not to be
`identified because the latest developments are not public. Teva declined to comment,
`Allergan did not immediately respond to requests for comment. (Reporting by Carl
`O'Donnell; Editing by David Gregorio)
`
`More from Reuters
`
`Sponsored Financial Content
`
` (?)
`
`Trumponomics favors pinstripes over
`blue collars
`
`Jim Rickards: "DO NOT buy any gold until
`you see this" Agora Financial
`
`A massive stock market rally is at our
`doorsteps, according to ... The Sovereign Society
`
`A jawdropping 21 month 0% interest rate
`credit card has been announce Next Advisor
`
`How 1 Man Turned $50,000 into $5.3 Million
` Investing Daily
`
`Donald Trump's Advice For Paying Off
`Mortgage (It's Genius!) Bills.com
`
`Swimming: Thirteen
`yearold rips suit but
`wins her heat | 7 Aug
`
`Obama warns Trump
`not to spread details
`of security briefings
`| 4 Aug
`
`Commentary: Here’s
`how a U.S.China war
`could play out | 9 Aug
`
`Hollande says will
`stay true to values
`after Trump swipe at
`France | 28 Jul
`
`Home flight
`simulator in MH370
`captain's home
`plotted Indian Ocean
`course: JACC | 28 Jul
`
`Beach Volleyball:
`Crowd taunts U.S.
`players with 'Zika'
`jeers | 7 Aug
`
`RIO OLYMPICS IN PICTURES
`
`http://www.reuters.com/article/allerganmatevapharmindassetsidUSL2N1820VD
`
`1/4
`
`Dr. Reddy's Labs. v. Indivior UK Ltd, IPR2016-01113
`INDIVIOR EX. 2008 - 1/4
`
`
`
`8/10/2016
`
`Teva Pharm finalizing asset sales to clear Allergan deal source | Reuters
`
`Trump 'not thrilled'
`with debate dates,
`Clinton vows 'to be
`there' | 31 Jul
`
`Trump fires back at
`Obama, says Clinton
`'unfit' for government
`| 2 Aug
`
`'Give them a bloody
`nose': Xi pressed for
`stronger South China
`Sea response | 31 Jul
`
`No plans to release
`tax returns as
`pressure mounts,
`Trump aide says
`| 27 Jul
`
`From The Web
`
`MORNING BRIEFING: A call to arms? Or a polite request to vote? VIEW MORE
`
`Highlights from Day 4
`
`
`by Taboola
`Sponsored Links
`
`
`
`
`
`Olympic bus hit by gunfire
`
`Find the Lowest Prices on
`Prescriptions
`GoodRx
`
`10 SUVs (Under $25,000) That
`Are the Cream of the Crop
`Kelley Blue Book
`
`Guide to a Hip Home Bar
`Cost Plus World Market
`
`Serena eliminated in shock upset
`
`PHOTOS OF THE DAY
`
`Are you a strategic thinker? Test
`your skills with millions of…
`Sparta Free Online Game
`
`Handmade Gifts for the Entire
`Family in Virginia Beach
`Visit Virginia Beach
`
`10 Hacks for the Best Sleep of
`Your Life
`Casper
`
`Sponsored Topics
`
`1.
`
`2.
`
`3.
`
`4.
`
`Refinancing a Mortgage Loan
`
`Cheapest Cable TV Packages
`
`Top 10 Internet Service Providers
`
`Best Cars to Own
`
`5.
`
`6.
`
`7.
`
`8.
`
`Retirement Annuity Rates
`
`Luxury SUV Deals
`
`Highest Paying Annuities
`
`Best Cloud Services of 2016
`
`TRENDING ON REUTERS
`
`Out of sight, out of mind? Europe's migrant
`crisis still simmers
`
`'Selfdriving' in spotlight again as China
`sees first Tesla autopilot crash
`
`Oneinfive U.S. Republicans want Trump
`to drop out: Reuters/Ipsos poll
`
`Exclusive: Vietnam moves new rocket
`launchers into disputed South China Sea
`sources
`
`Commentary: What the U.S. should learn
`from Britain’s dying navy
`
`1
`2
`3
`4
`
`5
`
`http://www.reuters.com/article/allerganmatevapharmindassetsidUSL2N1820VD
`
`2/4
`
`Dr. Reddy's Labs. v. Indivior UK Ltd, IPR2016-01113
`INDIVIOR EX. 2008 - 2/4
`
`
`
`8/10/2016
`
`Teva Pharm finalizing asset sales to clear Allergan deal source | Reuters
`
`MORNING BRIEFING: A call to arms? Or a polite request to vote? VIEW MORE
`
`Patents & Entrepreneurial Universities
`Measuring and evaluating academic innovation
`
`Demonstrating Impact to Funders
`Understanding your University's Rankings
`Highly Cited Researchers: Mazen Omar Hasna
`
`>
`
`>
`
`>
`
`Sponsored Financial Content
`
` (?)
`
`Many people are buying the WRONG kind of
`gold You may be one of them Agora Financial
`
`Donald Trump's Advice For Paying Off
`Mortgage (It's Genius!) Bills.com
`
`The Motley Fool Gives "Total Conviction" Buy
`Signal The Motley Fool
`
`A massive stock market rally is at our
`doorsteps, according to ... The Sovereign Society
`
`Before Applying For A Citi Card, Check If You
`PreQualify Citi
`
`KEY RATES
`
`MORTGAGE HOME EQUITY SAVINGS AUTO CREDIT CARDS
`
`See today's average mortgage rates across the country.
`
`TYPE
`30Year Fixed
`
`15Year Fixed
`
`10Year Fixed
`
`5/1Year ARM
`
`30Year Fixed Refi
`
`15Year Fixed Refi
`
`5/1 ARM Refi
`
`30Year Fixed Jumbo
`
`TODAY
`3.40%
`
`2.68%
`
`2.66%
`
`2.86%
`
`3.44%
`
`2.71%
`
`3.03%
`
`1 MO
`3.64%
`
`2.67%
`
`2.67%
`
`2.86%
`
`3.47%
`
`2.68%
`
`2.99%
`
`4.23%
`3.88%
`Rates may include points.
`
`SOURCE: BANKRATE.COM
`SEE MORE KEY RATE DATA
`
`SPONSORED TOPICS
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`The Best Vitamins for Memory
`
`2016 Best CRM Software
`
`Retirement Planning Calculator
`
`Luxury Crossover SUVs
`
`Safe Retirement Investments
`
`Retirement Annuities
`
`http://www.reuters.com/article/allerganmatevapharmindassetsidUSL2N1820VD
`
`3/4
`
`Dr. Reddy's Labs. v. Indivior UK Ltd, IPR2016-01113
`INDIVIOR EX. 2008 - 3/4
`
`
`
`8/10/2016
`
`Teva Pharm finalizing asset sales to clear Allergan deal source | Reuters
`
`MORNING BRIEFING: A call to arms? Or a polite request to vote? VIEW MORE
`
`Follow Reuters:
`
`Subscribe: Feeds | Newsletters | Podcasts | Apps
`
`Reuters News Agency | Brand Attribution Guidelines | Delivery Options
`Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news,
`world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available
`on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:
`
`EIKON
`Information, analytics and
`exclusive news on
`financial markets -
`delivered in an intuitive
`desktop and mobile
`interface
`
`ELEKTRON
`Everything you need to
`empower your workflow
`and enhance your
`enterprise data
`management
`
`WORLD-CHECK
`Screen for heightened risk
`individual and entities
`globally to help uncover
`hidden risks in business
`relationships and human
`networks
`
`WESTLAW
`Build the strongest
`argument relying on
`authoritative content,
`attorney-editor expertise,
`and industry defining
`technology
`
`ONESOURCE
`The most comprehensive
`solution to manage all
`your complex and ever-
`expanding tax and
`compliance needs
`
`CHECKPOINT
`The industry leader for
`online information for tax,
`accounting and finance
`professionals
`
`All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
`
`© 2016 Reuters. All Rights Reserved.
`
`Site Feedback Corrections Advertise With Us Advertising Guidelines
`
` AdChoices Terms of Use Privacy Policy
`
`http://www.reuters.com/article/allerganmatevapharmindassetsidUSL2N1820VD
`
`4/4
`
`Dr. Reddy's Labs. v. Indivior UK Ltd, IPR2016-01113
`INDIVIOR EX. 2008 - 4/4
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
